journal article·2017-12

Nanocomposite hydrogels stabilized by self-assembled multivalent bisphosphonate-magnesium nanoparticles mediate sustained release of magnesium ion and promote in-situ bone regeneration

Kunyu Zhang, Sien Lin, Qian Feng, Chaoqun Dong, Yanhua Yang, Gang Li, Liming Bian

Acta Biomaterialia· Volume 64
Publisher page

Abstract

Hydrogels are appealing biomaterials for applications in regenerative medicine due to their tunable physical and bioactive properties. Meanwhile, therapeutic metal ions, such as magnesium ion (Mg2+), not only regulate the cellular behaviors but also stimulate local bone formation and healing. However, the effective delivery and tailored release of Mg2+ remains a challenge, with few reports on hydrogels being used for Mg2+ delivery. Bisphosphonate exhibits a variety of specific bioactivities and excellent binding affinity to multivalent cations such as Mg2+. Herein, we describe a nanocomposite hydrogel based on hyaluronic acid and self-assembled bisphosphonate-magnesium (BP-Mg) nanoparticles. These nanoparticles bearing acrylate groups on the surface not only function as effective multivalent crosslinkers to strengthen the hydrogel network structure, but also promote the mineralization of hydrogels and mediate sustained release of Mg2+. The released Mg2+ ions facilitate stem cell adhesion and spreading on the hydrogel substrates in the absence of cell adhesion ligands, and promote osteogenesis of the seeded hMSCs in vitro. Furthermore, the acellular porous hydrogels alone can support in situ bone regeneration without using exogenous cells and inductive agents, thereby greatly simplifying the approaches of bone regeneration therapy. Statement of significance In this study, we developed a novel bioactive nanocomposite hydrogel based on hyaluronic acid and self-assembled bisphosphonate-magnesium (BP-Mg) nanoparticles. Such hydrogels are stabilized by the multivalent crosslinking domains formed by the aggregation of Ac-BP-Mg NPs, and therefore show enhanced mechanical properties, improved capacity for mineralization, and controlled release kinetics of Mg2+. Moreover, the released Mg2+ can enhance cell adhesion and spreading, and further promote the osteogenic differentiation of hMSCs. Owing to these unique properties, these acellular hydrogels alone can well facilitate the in vivo bone regeneration at the intended sites. We believe that the strategy reported in this work opens up a new route to develop biopolymer-based nanocomposite hydrogels with enhanced physical and biological functionalities for regenerative medicine.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Magnesium Alloys: Properties and Applications · Bone health and treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (57)

Show source-provided references
1. Biomimetic porous scaffolds for bone tissue engineering10.1016/j.mser.2014.04.001 ↗
2. Incidence of donor site morbidity following harvesting from iliac crest or RIA graft10.1016/j.injury.2014.10.034 ↗
3. Long-term clinical study and multiscale analysis of in vivo biodegradation mechanism of Mg alloy10.1073/pnas.1518238113 ↗
5. Magnesium ion stimulation of bone marrow stromal cells enhances osteogenic activity, simulating the effect of magnesium alloy degradation10.1016/j.actbio.2014.02.002 ↗
6. Multifunctions of dual Zn/Mg ion co-implanted titanium on osteogenesis, angiogenesis and bacteria inhibition for dental implants10.1016/j.actbio.2016.11.067 ↗
7. Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants
8. Bone formation controlled by biologically relevant inorganic ions: role and controlled delivery from phosphate-based glasses10.1016/j.addr.2012.05.015 ↗
9. In vivo stimulation of bone formation by aluminum and oxygen plasma surface-modified magnesium implants10.1016/j.biomaterials.2013.08.052 ↗
10. Disorders involving calcium, phosphorus, and magnesium10.1016/j.pop.2008.01.007 ↗
11. Soar · Resuscitation · 2010 · 81 · 140010.1016/j.resuscitation.2010.08.015 ↗
12. Influence of magnesium substitution on a collagen-apatite biomaterial on the production of a calcifying matrix by human osteoblasts10.1002/(SICI)1097-4636(19981215)42:4<626::AID-JBM20>3.0.CO;2-S ↗
13. Osteoblast response to magnesium ion-incorporated nanoporous titanium oxide surfaces10.1111/j.1600-0501.2010.01944.x ↗
14. Engineered polycaprolactone-magnesium hybrid biodegradable porous scaffold for bone tissue engineering10.1016/j.pnsc.2014.08.013 ↗
15. Long-term in vivo degradation behavior and near-implant distribution of resorbed elements for magnesium alloys WZ21 and ZX5010.1016/j.actbio.2016.06.025 ↗
16. Biocompatibility and degradation of LAE442-based magnesium alloys after implantation of up to 3.5 years in a rabbit model10.1016/j.actbio.2016.08.002 ↗
17. In vivo study of magnesium plate and screw degradation and bone fracture healing10.1016/j.actbio.2015.02.010 ↗
18. Vascularized bone grafting fixed by biodegradable magnesium screw for treating osteonecrosis of the femoral head10.1016/j.biomaterials.2015.11.038 ↗
19. Current status on clinical applications of magnesium-based orthopaedic implants: a review from clinical translational perspective10.1016/j.biomaterials.2016.10.017 ↗
20. Fast escape of hydrogen from gas cavities around corroding magnesium implants10.1016/j.actbio.2012.10.008 ↗
21. Recent advances on the development of magnesium alloys for biodegradable implants10.1016/j.actbio.2014.07.005 ↗
22. The effect of hydrogen gas evolution of magnesium implant on the postimplantation mortality of rats
23. Prodrugs of phosphates and phosphonates10.1021/jm701260b ↗
24. Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells10.1016/j.biomaterials.2007.10.040 ↗
25. Enhanced initial bone regeneration with inorganic polyphosphate-adsorbed hydroxyapatite10.1016/j.actbio.2009.12.055 ↗
26. Enhancing osteogenic differentiation of MC3T3-E1 cells by immobilizing inorganic polyphosphate onto hyaluronic acid hydrogel10.1021/bm501356c ↗
27. Bisphosphonate-linked hyaluronic acid hydrogel sequesters and enzymatically releases active bone morphogenetic protein-2 for induction of osteogenic differentiation10.1021/bm400639e ↗
28. Bone-targeting macromolecular therapeutics10.1016/j.addr.2004.12.011 ↗
29. Bisphosphonate chelating agents: complexation of Fe(III) and Al(III) by 1-phenyl-1-hydroxymethylene bisphosphonate and its analogues10.1016/S0020-1693(02)00918-0 ↗
30. Structural study of metal complexes of bisphosphonate amide ester: copper, magnesium, zinc and cadmium complexes of (dichloromethylene) bisphosphonic acid P-piperidinium-P '-methyl ester10.1039/B616077H ↗
31. Hyaluronic acid hydrogels for biomedical applications10.1002/adma.201003963 ↗
32. 25th Anniversary Article: Rational design and applications of hydrogels in regenerative medicine10.1002/adma.201303233 ↗
33. Mechanically resilient, injectable, and bioadhesive supramolecular gelatin hydrogels crosslinked by weak host-guest interactions assist cell infiltration and in situ tissue regeneration10.1016/j.biomaterials.2016.05.043 ↗
34. Double-network hydrogels strongly bondable to bones by spontaneous osteogenesis penetration10.1002/adma.201601030 ↗
35. Robust biopolymeric supramolecular “host-guest macromer” hydrogels reinforced by in situ formed multivalent nanoclusters for cartilage regeneration10.1021/acs.macromol.5b02527 ↗
36. A mineralized high strength and tough hydrogel for skull bone regeneration10.1002/adfm.201604327 ↗
37. Natural-based nanocomposites for bone tissue engineering and regenerative medicine: a review10.1002/adma.201403354 ↗
38. Clay: new opportunities for tissue regeneration and biomaterial design10.1002/adma.201301034 ↗
39. Controlling mechanical properties of cell-laden hydrogels by covalent incorporation of graphene oxide10.1002/smll.201302182 ↗
40. Highly extensible, tough, and elastomeric nanocomposite hydrogels from poly(ethylene glycol) and hydroxyapatite nanoparticles10.1021/bm200027z ↗
41. Hierarchically structured free-standing hydrogels with liquid crystalline domains and magnetic nanoparticles as dual physical cross-linkers10.1021/ja208349x ↗
42. The influence of hyaluronic acid hydrogel crosslinking density and macromolecular diffusivity on human MSC chondrogenesis and hypertrophy10.1016/j.biomaterials.2012.09.052 ↗
43. Self-healing hybrid nanocomposites consisting of bisphosphonated hyaluronan and calcium phosphate nanoparticles10.1016/j.biomaterials.2014.05.003 ↗
44. Hydrogels functionalized with N-cadherin mimetic peptide enhance osteogenesis of hMSCs by emulating the osteogenic niche10.1016/j.biomaterials.2015.10.072 ↗
45. Crystal-growth of calcium phosphates in the presence of magnesium-ions10.1021/la00061a019 ↗
46. Direct “click” synthesis of hybrid bisphosphonate-hyaluronic acid hydrogel in aqueous solution for biomineralization10.1021/cm300298n ↗
47. Incorporation of magnesium ions into photo-crosslinked alginate hydrogel enhanced cell adhesion ability10.1002/term.2011 ↗
48. Binding affinity of metal ions to the CD11b A-domain is regulated by integrin activation and ligands10.1074/jbc.M402901200 ↗
49. Regulation of alpha-2-beta-1-mediated fibroblast migration on type-I collagen by shifts in the concentrations of extracellular Mg2+ and Ca2+10.1083/jcb.117.5.1109 ↗
50. A minimized human integrin alpha(5)beta(1) that retains ligand recognition10.1074/jbc.275.8.5888 ↗
51. Effect of the biodegradation rate controlled by pore structures in magnesium phosphate ceramic scaffolds on bone tissue regeneration in vivo10.1016/j.actbio.2016.08.039 ↗
52. Biocompatibility of magnesium phosphate minerals and their stability under physiological conditions10.1016/j.actbio.2011.02.007 ↗
53. Effects of extracellular magnesium extract on the proliferation and differentiation of human osteoblasts and osteoclasts in coculture10.1016/j.actbio.2015.08.042 ↗
54. High magnesium inhibits human osteoblast differentiation in vitro10.1684/mrh.2011.0271 ↗
56. Systematic review: bisphosphonates and osteonecrosis of the jaws10.7326/0003-4819-144-10-200605160-00009 ↗
57. Adverse event (AE) reporting of oral clodronate with emphasis on osteonecrosis of the jaw